null Suzanne Morin, MD, M.Sc., FRCP, FACP

Scientist, RI-MUHC, 5252 de Maisonneuve site

Metabolic Disorders and Complications Program

Centre for Outcomes Research and Evaluation

Associate Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

Department of Medicine, Division of Internal Medicine, MUHC



Osteoporosis • fractures • bone mineral density • administrative healthcare databases • atypical femur fractures • rehabilitation • clinical practice guidelines

Research Focus

My research focuses on the evaluation of outcomes of osteoporosis and its treatment, and implementation of health system improvement initiatives for patients who have sustained fractures such as secondary fracture prevention, pain management and functional recovery. I also study the pathogenesis of bisphosphonate-associated atypical femur fractures and safety of calcium supplements on vascular health in postmenopausal women. I am a leader in clinical practice guidelines development for the management and prevention of osteoporosis and fractures.

Selected Publications

Click on Pubmed to see my current publications list

  • Performance of FRAX in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study. Leslie WD, Morin SN, Lix LM, Niraula S, McCloskey EV, Johansson H, Harvey NC, Kanis JA. J Bone Miner Res. 2019 May 9. PMID: 31069862.

  • Factors Associated With Bone Density Monitoring While on Antiosteoporosis Treatment in Routine Clinical Practice: A Registry-Based Cohort Study. Leslie WD, Morin SN, Martineau P, Bryanton M, Lix LM. J Clin Densitom. 2019 Mar 21. PMID: 31003744.

  • Mazzetti G, Berger C, Leslie WD, Hans D, Langstemo L, Hanley DA, Kovacs CS, Prior JC, Kaiser SM, Davison KS, Josse RG, Papaioannou A, Adachi JD, Goltzman D, Morin SN, for the CaMos Research Group. Densitometer-specific differences in the correlation between body mass index and lumbar spine trabecular bone score. J Clin Densitom. 2016 Dec; pii: S1094-6950(16)30185-8. PMID: 28034592.

  • Leslie WD, Majumdar SR, Morin SN, Lix LM. Change in bone mineral density is an indicator of treatment-related antifracture effect in routine clinical practice: A registry-based cohort study. Ann Intern Med. 2016; 165 (7): 465-472. PMID: 27428723.

  • Morin SN, Wall M, Belzile EL, Godbout B, Moser TP, Michou L, Ste-Marie L-G, de Guise JA, Rahme E, Brown JP. Assessment of Femur Geometrical Parameters using EOS™ Imaging Technology in Patients with Atypical Femur Fractures: Preliminary Results. Bone. 2015 Nov 2; 83:184-189. PMID: 26541215.